Skip to main content
. 2022 Jun 30;162(4):899–919. doi: 10.1016/j.chest.2022.06.026

Table 1.

Baseline Characteristics of the Study Group

Characteristic NCS Arm (n = 91) Placebo Arm (n = 43)
Age, y 8.2 ± 2.2 8.1 ± 2.0
Female 47 (52%) 20 (47%)
Race
 African American 74 (81%) 35 (81%)
 White 11 (12%) 5 (12%)
 Other 6 (7%) 3 (7%)
Hispanic ethnicity 7 (8%) 5 (12%)
Anthropometric measures
 Height, cm 131.9 ± 15.5 131.5 ± 13.5
 Height z score 0.6 ± 0.9 0.6 ± 0.8
 Weight, kg 37.5 ± 18.2 36.3 ± 15.8
 Weight z score 1.2 ± 1.1 1.1 ± 1.1
Weight class
 Obese (BMI ≥ 95th percentile) 33 (36%) 15 (35%)
 Overweight or obese (BMI ≥ 85th percentile) 50 (55%) 21 (49%)
 Failure to thrive (weight < 5th percentile) 2 (2%) 0
Upper airway measures
 Friedman tongue position 2.8 ± .9 2.9 ± .8
 Mallampati score 2.3 ± .9 2.5 ± 1
 Right tonsil size 2.5 ± .9 2.6 ± .8
 Left tonsil size 2.5 ± .8 2.6 ± .8
 Maternal education less than high school 6 (7%) 2 (5%)
 Household income less than $30,000/y 44 (48%) 24 (56%)
 Fall/winter at time of randomization 43 (47%) 22 (51%)
 Atopy/asthma at time of randomization 34 (37%) 17 (40%)
 Current steroid use at time of randomization 4 (4%) 3 (7%)

Data are presented as mean ± SD unless otherwise indicated.